• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Multifactorial audit of invasive cervical cancer: key lessons for the National Screening Programme.浸润性宫颈癌的多因素审计:国家筛查计划的关键经验教训。
J Clin Pathol. 1995 May;48(5):405-7. doi: 10.1136/jcp.48.5.405.
2
Audit of deaths from cervical cancer: proposal for an essential component of the National Screening Programme.宫颈癌死亡情况审计:国家筛查计划重要组成部分的提案。
J Clin Pathol. 1994 Jan;47(1):27-8. doi: 10.1136/jcp.47.1.27.
3
An audit of cervical cancer deaths in Nottingham.诺丁汉市宫颈癌死亡情况审计。
Cytopathology. 1992;3(2):79-83. doi: 10.1111/j.1365-2303.1992.tb00029.x.
4
An audit of a cervical smear screening programme.一项宫颈涂片筛查计划的审计。
N Z Med J. 1989 Jul 26;102(872):374-6.
5
Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.法医学事务。国际细胞学会特别工作组总结。《迈向21世纪的诊断细胞学:一次国际专家会议及教程》
Acta Cytol. 1998 Jan-Feb;42(1):76-119; discussion 120-32. doi: 10.1159/000331537.
6
Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.通过数据关联监测新西兰国家宫颈癌筛查计划的执行情况。
N Z Med J. 2009 Oct 30;122(1305):15-25.
7
An examination of the role of opportunistic smear taking in the NHS cervical screening programme using data from the CSEU cervical screening cohort study.利用CSEU宫颈筛查队列研究的数据,对国民保健服务(NHS)宫颈筛查计划中机会性涂片检查的作用进行考察。
BJOG. 2007 Nov;114(11):1408-13. doi: 10.1111/j.1471-0528.2007.01467.x. Epub 2007 Sep 5.
8
Negative cytology preceding cervical cancer: causes and prevention.宫颈癌前的阴性细胞学检查:原因与预防
J Clin Pathol. 1993 Aug;46(8):700-2. doi: 10.1136/jcp.46.8.700.
9
A smear on audit. Implications of the Leicester cervical smear audit.宫颈涂片检查审核中的问题。莱斯特宫颈涂片检查审核的影响。
BJOG. 2003 Jul;110(7):646-8. doi: 10.1046/j.1471-0528.2003.02015.x.
10
The characteristics of false negative cervical smears--implications for the UK cervical cancer screening programme.宫颈涂片假阴性的特征——对英国宫颈癌筛查计划的启示
J Clin Pathol. 1999 May;52(5):358-62. doi: 10.1136/jcp.52.5.358.

引用本文的文献

1
[Reevaluation of cytological smears in patients with cervical cancer. Regional quality assurance program with the cooperation of the Austrian Society for Cytology, the Carinthian Medical Association and the Carinthian Ministry of Health].
Pathologe. 2007 Sep;28(5):339-45. doi: 10.1007/s00292-007-0931-9.
2
A systematic review of postcoital bleeding and risk of cervical cancer.性交后出血与宫颈癌风险的系统评价
Br J Gen Pract. 2006 Jun;56(527):453-60.
3
Multifactorial audit of invasive cervical cancer.浸润性宫颈癌的多因素审计
J Clin Pathol. 1995 Aug;48(8):785. doi: 10.1136/jcp.48.8.785-b.
4
Multifactorial audit of invasive cervical cancer.浸润性宫颈癌的多因素审计
J Clin Pathol. 1995 Aug;48(8):785. doi: 10.1136/jcp.48.8.785-a.

本文引用的文献

1
Negative cytology preceding cervical cancer: causes and prevention.宫颈癌前的阴性细胞学检查:原因与预防
J Clin Pathol. 1993 Aug;46(8):700-2. doi: 10.1136/jcp.46.8.700.
2
Audit of deaths from cervical cancer: proposal for an essential component of the National Screening Programme.宫颈癌死亡情况审计:国家筛查计划重要组成部分的提案。
J Clin Pathol. 1994 Jan;47(1):27-8. doi: 10.1136/jcp.47.1.27.
3
Cervical cytology internal quality assurance--what are the national standards?宫颈细胞学内部质量保证——国家标准是什么?
Cytopathology. 1994 Aug;5(4):207-10. doi: 10.1111/j.1365-2303.1994.tb00421.x.
4
Cervical cytology external and internal quality assurance: a comparative appraisal.宫颈细胞学检查的外部和内部质量保证:比较评估
J Clin Pathol. 1995 Feb;48(2):95-7. doi: 10.1136/jcp.48.2.95.
5
Cervical smear histories of 500 women with invasive cervical cancer in Yorkshire.约克郡500名浸润性宫颈癌女性的宫颈涂片检查史。
Br Med J (Clin Res Ed). 1984 Oct 6;289(6449):896-8. doi: 10.1136/bmj.289.6449.896.
6
Are patients with abnormal cervical smears adequately managed?宫颈涂片异常的患者是否得到了妥善处理?
Br Med J (Clin Res Ed). 1984 Oct 6;289(6449):891-4. doi: 10.1136/bmj.289.6449.891.
7
Investigation of non-responders at a cervical cancer screening clinic in Manchester.曼彻斯特一家宫颈癌筛查诊所无反应者的调查。
Br Med J (Clin Res Ed). 1988 Apr 9;296(6628):1041-2. doi: 10.1136/bmj.296.6628.1041.
8
Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s.宫颈细胞学检查结果为阴性后诊断出的宫颈癌:20世纪80年代的情况
BMJ. 1990 Jun 23;300(6740):1622-6. doi: 10.1136/bmj.300.6740.1622.
9
Screening for cancer of the cervix in elderly women.老年女性宫颈癌筛查
Lancet. 1990 Jan 13;335(8681):97-9. doi: 10.1016/0140-6736(90)90552-g.
10
An audit of cervical cancer deaths in Nottingham.诺丁汉市宫颈癌死亡情况审计。
Cytopathology. 1992;3(2):79-83. doi: 10.1111/j.1365-2303.1992.tb00029.x.

浸润性宫颈癌的多因素审计:国家筛查计划的关键经验教训。

Multifactorial audit of invasive cervical cancer: key lessons for the National Screening Programme.

作者信息

Slater D N

机构信息

Department of Histopathology and Cytopathology, Rotherham NHS Hospitald Trust.

出版信息

J Clin Pathol. 1995 May;48(5):405-7. doi: 10.1136/jcp.48.5.405.

DOI:10.1136/jcp.48.5.405
PMID:7629283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC502612/
Abstract

AIMS

To audit factors associated with the development of invasive cervical cancer.

METHODS

Twenty cases of invasive cervical cancer in one health district for 1991-93 were audited by multifactorial analysis.

RESULTS

The average age was 53 years with 20% (4/20) aged over 65 years. Of the patients, 45% (9/20) were identified by a cervical smear, with 40% (8/20) from the National Screening Programme (NSP) and 5% (1/20) opportunistically; 30% (6/20) had not received a smear, 10% (2/20) being aged under 65 and 20% 65 or over. Those with no smear had all been hospital patients during the previous five years. No response to a smear invitation occurred in 5%. In 20%, there had been a true negative smear two to five years previously. Inappropriate laboratory diagnosis or inappropriate clinical management occurred in 30% and 15% (3/20), respectively. In 20%, two or more factors were present in the same patient.

CONCLUSIONS

Why cervical cancer occurs after a true negative smear requires research and women aged over 65 with no smear must be targeted. Failsafe systems should incorporate inadequate smears and smear adequacy should be given priority in quality assurance (QA) and training. False negative reports must be minimised but accepted as an inherent part of the NSP and not an automatic indicator of poor laboratory performance. Comprehensive national QA standards are required, to which providers must conform. Postcoital bleeding is an absolute indication for a smear and, when appropriate, opportunistic smears offered at all hospital attendance. Cervical cancer audit must be guaranteed access to all clinical and laboratory information and be seen as a means to improve the effectiveness and quality of the NSP.

摘要

目的

审核与浸润性宫颈癌发生相关的因素。

方法

通过多因素分析对某一健康区1991 - 1993年的20例浸润性宫颈癌病例进行审核。

结果

平均年龄为53岁,20%(4/20)的患者年龄超过65岁。在这些患者中,45%(9/20)通过宫颈涂片检查发现,其中40%(8/20)来自国家筛查计划(NSP),5%(1/20)为机会性筛查;30%(6/20)未接受过涂片检查,其中10%(2/20)年龄在65岁以下,20%年龄在65岁及以上。未接受涂片检查的患者在过去五年中均为住院患者。5%的患者未对涂片检查邀请做出回应。20%的患者在两到五年前曾有过真阴性涂片检查结果。分别有30%和15%(3/20)的患者存在实验室诊断不当或临床管理不当的情况。20%的患者存在两种或更多因素。

结论

在出现真阴性涂片检查结果后为何会发生宫颈癌需要进行研究,必须将未接受涂片检查的65岁以上女性作为目标人群。故障安全系统应纳入涂片检查不充分的情况,并且在质量保证(QA)和培训中应优先考虑涂片的充分性。必须尽量减少假阴性报告,但应将其视为NSP的固有组成部分,而不是实验室表现不佳的自动指标。需要全面的国家QA标准,提供者必须遵守。性交后出血是涂片检查的绝对指征,并且在适当的时候,应在所有住院就诊时提供机会性涂片检查。宫颈癌审核必须能够获取所有临床和实验室信息,并应被视为提高NSP有效性和质量的一种手段。